Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma
Open Access
- 9 April 2010
- journal article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 9 (1), 74
- https://doi.org/10.1186/1476-4598-9-74
Abstract
The goal of this study was to understand gene expression signatures of hepatocellular carcinoma (HCC) recurrence in subjects with hepatitis C virus (HCV) infection. Recurrence-free survival (RFS) following curative resection of HCC in subjects with HCV is highly variable. Traditional clinico-pathological endpoints are recognized as weak predictors of RFS. It has been suggested that gene expression profiling of HCC and nontumoral liver tissue may improve prediction of RFS, aid in understanding of the underlying liver disease, and guide individualized patient management. Frozen samples of the tumors and nontumoral liver were obtained from 47 subjects with HCV-associated HCC. Additional nontumoral liver samples were obtained from HCV-free subjects with metastatic liver tumors. Gene expression profiling data was used to determine the molecular signature of HCV-associated HCC and to develop a predictor of RFS. The molecular profile of the HCV-associated HCC confirmed central roles for MYC and TGFβ1 in liver tumor development. Gene expression in tumors was found to have poor predictive power with regards to RFS, but analysis of nontumoral tissues yielded a strong predictor for RFS in late-recurring (>1 year) subjects. Importantly, nontumoral tissue-derived gene expression predictor of RFS was highly significant in both univariable and multivariable Cox proportional hazard model analyses. Microarray analysis of the nontumoral tissues from subjects with HCV-associated HCC delivers novel molecular signatures of RFS, especially among the late-recurrence subjects. The gene expression predictor may hold important insights into the pathobiology of HCC recurrence and de novo tumor formation in cirrhotic patients.Keywords
This publication has 43 references indexed in Scilit:
- Major achievements in hepatocellular carcinomaThe Lancet, 2009
- The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biologyThe Esophagus, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Design and Endpoints of Clinical Trials in Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 2008
- Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: Recent trendsInternational Journal of Cancer, 2007
- Specific Gene-Expression Profiles of Noncancerous Liver Tissue Predict the Risk for Multicentric Occurrence of Hepatocellular Carcinoma in Hepatitis C Virus–Positive PatientsAnnals of Surgical Oncology, 2006
- Hepatocellular carcinoma: Recent trends in JapanGastroenterology, 2004
- Hepatocellular carcinomaThe Lancet, 2003
- Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular CarcinomaAnnals of Surgery, 2003
- Risk factors for intrahepatic recurrence in human small hepatocellular carcinomaGastroenterology, 1995